Unit for Social and Community Psychiatry, Barts' and The London School of Medicine
Department of Psychiatry and Behavioural Sciences, University College London and Camden and Islington Mental Health and Social Care Trust
Department of General Psychiatry, St George's Hospital Medical School, London
Department of Psychiatry and Behavioural Sciences, University College London and Camden and Islington Mental Health and Social Care Trust
Sainsbury Centre for Mental Health
Biostatistics Unit, Cambridge
Department of General Psychiatry, St George's Hospital Medical School, London
Correspondence: Professor Stefan Priebe, Unit for Social and Community Psychiatry, Newham Centre for Mental Health, London E13 8SP, UK. E-mail: s.priebe{at}qmul.ac.uk
Declaration of interest Funding provided by the Department of Health.
See Parts1and 2, pp.
132147, this issue.
Background Although the model of assertive outreach has been widely adopted, it is unclear who receives assertive outreach in practice and what outcomes can be expected under routine conditions.
Aims To assess patient characteristics and outcome in routine assertive outreach services in the UK.
Method Patients (n=580) were sampled from 24 assertive outreach teams in London. Outcomes days spent in hospital and compulsory hospitalisation were assessed over a 9-month follow-up.
Results The 6-month prevalence rate of substance misuse was 29%, and 35% of patients had been physically violent in the past 2 years. During follow-up, 39% were hospitalised and 25% compulsorily admitted. Outcome varied significantly between team types. These differences did not hold true when baseline differences in patient characteristics were controlled for.
Conclusions Routine assertive outreach serves a wide range of patients with significant rates of substance misuse and violent behaviour. Over a 9-month period an average of 25% of assertive outreach patients can be expected to be hospitalised compulsorily. Differences in outcome between team types can be explained by differences in patient characteristics.
Related articles in BJP:
This article has been cited by other articles:
![]() |
T. R. E. Barnes, A. Shingleton-Smith, and C. Paton Antipsychotic long-acting injections: prescribing practice in the UK The British Journal of Psychiatry, November 1, 2009; 195(52): S37 - S42. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Claassen, W. K. Fakhoury, R. Ford, and S. Priebe Money for medication: financial incentives to improve medication adherence in assertive outreach Psychiatr. Bull., January 1, 2007; 31(1): 4 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schneider, T. Brandon, D. Wooff, J. Carpenter, and R. Paxton Assertive outreach: policy and reality Psychiatr. Bull., March 1, 2006; 30(3): 89 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. PRIEBE, J. WATTS, M. CHASE, and A. MATANOV Processes of disengagement and engagement in assertive outreach patients: qualitative study The British Journal of Psychiatry, November 1, 2005; 187(5): 438 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Priebe, W. Fakhoury, I. White, J. Watts, P. Bebbington, J. Billings, T. Burns, S. Johnson, M. Muijen, I. Ryrie, et al. Characteristics of teams, staff and patients: associations with outcomes of patients in assertive outreach The British Journal of Psychiatry, October 1, 2004; 185(4): 306 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Cornwall Assertive outreach in Tyneside The British Journal of Psychiatry, November 1, 2003; 183(5): 461 - 461. [Full Text] [PDF] |
||||
![]() |
J. BILLINGS, S. JOHNSON, P. BEBBINGTON, A. GREAVES, S. PRIEBE, M. MUIJEN, I. RYRIE, J. WATTS, I. WHITE, and C. WRIGHT Assertive outreach teams in London: staff experiences and perceptions: Pan-London Assertive Outreach Study, Part 2 The British Journal of Psychiatry, August 1, 2003; 183(2): 139 - 147. [Abstract] [Full Text] [PDF] |
||||